Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
0.9901
-0.0065 (-0.65%)
Nov 20, 2025, 12:33 PM EST - Market open
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $99.24 million as of November 20, 2025. Its market cap has decreased by -36.74% in one year.
Market Cap
99.24M
Enterprise Value
91.06M
1-Year Change
-36.74%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $99.24M, an increase of 42.24%. That is a compound annual growth rate of 5.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 99.24M | -5.42% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | 71.68M | -21.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |